Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoshu Bi

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Elife|December 27, 2024
Unveiling chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencingYiwei Huang, Gujie Wu, Guoshu Bi, et al.
Nature Communications|November 11, 2025
Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 statusYunyi Bian, Guangyao Shan, Guoshu Bi, et al.
Cell Discovery|October 21, 2020
Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodulesTao Lu, Xiaodong Yang, Yu Shi, et al.
Cancer Communications (London, England)|October 14, 2025
CD24 is a promising immunotherapeutic target for enhancing efficacy of third-generation EGFR-TKIs on EGFR-mutated lung cancerJiaqi Liang, Guoshu Bi, Xiaolong Huang, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Elife|December 27, 2024
Unveiling chemotherapy-induced immune landscape remodeling and metabolic reprogramming in lung adenocarcinoma by scRNA-sequencingYiwei Huang, Gujie Wu, Guoshu Bi, et al.
Nature Communications|November 11, 2025
Targeting polyamine metabolism and ferroptosis enhances the efficacy of KRAS-targeted therapy depending on KEAP1 statusYunyi Bian, Guangyao Shan, Guoshu Bi, et al.
Cell Discovery|October 21, 2020
Single-cell transcriptome atlas of lung adenocarcinoma featured with ground glass nodulesTao Lu, Xiaodong Yang, Yu Shi, et al.
Cancer Communications (London, England)|October 14, 2025
CD24 is a promising immunotherapeutic target for enhancing efficacy of third-generation EGFR-TKIs on EGFR-mutated lung cancerJiaqi Liang, Guoshu Bi, Xiaolong Huang, et al.
Pageof 8